SYSTEMATIC REVIEW
Published on 04 Dec 2025
Effectiveness and safety of tocilizumab in refractory noninfectious uveitis: a systematic review and meta-analysis
doi 10.3389/fphar.2025.1694311
- 405 views
- Frontiers in Pharmacology
- Inflammation Pharmacology
- Research Topics
- Volume II: Anti-Inflammatory Drug Development Focusing on Immune Mediated Diseases
Volume II: Anti-Inflammatory Drug Development Focusing on Immune Mediated Diseases
4,366
Total downloads
23k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 01 Dec 2025
Acetyl-11-keto-beta-boswellic acid ameliorates monosodium iodoacetate-induced osteoarthritis in rats: implications of HMGB1/TLR4/NF-κB and Nrf2/HO-1
doi 10.3389/fphar.2025.1694803
- 485 views
CLINICAL TRIAL
Published on 07 Oct 2025
Preemptive flurbiprofen axetil for sleep-pain-inflammation modulation after laparoscopic gynecological surgery: a prospective, parallel-group randomized controlled trial
doi 10.3389/fphar.2025.1659179
- 1,226 views
MINI REVIEW
Published on 16 Sep 2025
Promising therapeutics of enterovirus 71 infection: sunshine behind cloud
doi 10.3389/fphar.2025.1652159
- 1,868 views
- 1 citation
REVIEW
Published on 06 Aug 2025
Exploring dupilumab for asthma: from mechanistic insights to clinical outcomes, safety, and cost-effectiveness
doi 10.3389/fphar.2025.1631321
- 6,038 views
- 2 citations
ORIGINAL RESEARCH
Published on 25 Jul 2025
Unique compound with anti-allergic action: inhibition of Lyn kinase activity by KIRA6
doi 10.3389/fphar.2025.1625798
- 1,687 views
- 1 citation
ORIGINAL RESEARCH
Published on 07 Jul 2025
Antagonizing IL-6 receptor restores pancreatic tissue resident NK cells activation and ameliorates pancreatic injury in the mouse model of MASH
doi 10.3389/fphar.2025.1611637
- 1,927 views
- 1 citation
REVIEW
Published on 09 Jun 2025
Targeting the cGAS-STING pathway: emerging strategies and challenges for the treatment of inflammatory skin diseases
doi 10.3389/fphar.2025.1597443
- 2,386 views
- 1 citation
ORIGINAL RESEARCH
Published on 24 Apr 2025
S1PR4-dependent effects of Etrasimod on primary human myeloid immune cell activation
doi 10.3389/fphar.2025.1590816
- 2,949 views
